De novo production of the flavonoid naringenin in engineered Saccharomyces cerevisiae

被引:261
|
作者
Koopman, Frank [1 ,2 ,3 ]
Beekwilder, Jules [2 ,4 ,5 ]
Crimi, Barbara [1 ,2 ,3 ]
van Houwelingen, Adele [4 ]
Hall, Robert D. [2 ,4 ,5 ]
Bosch, Dirk [2 ,4 ,5 ]
van Maris, Antonius J. A. [1 ,3 ]
Pronk, Jack T. [1 ,2 ,3 ]
Daran, Jean-Marc [1 ,2 ,3 ]
机构
[1] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands
[2] Platform Green Synthet Biol, NL-2600 GA Delft, Netherlands
[3] Kluyver Ctr Genom Ind Fermentat, NL-2600 GA Delft, Netherlands
[4] Plant Res Int, NL-6700 AA Wageningen, Netherlands
[5] Ctr Biosyst Genom, NL-6700 AB Wageningen, Netherlands
关键词
Saccharomyces cerevisiae; Naringenin; de novo; Flavonoids; Metabolic engineering; TYROSINE AMMONIA-LYASE; ESCHERICHIA-COLI; IN-VIVO; BIOSYNTHESIS; YEAST; EXPRESSION; ARABIDOPSIS; GENE; PATHWAY; GENOME;
D O I
10.1186/1475-2859-11-155
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Flavonoids comprise a large family of secondary plant metabolic intermediates that exhibit a wide variety of antioxidant and human health-related properties. Plant production of flavonoids is limited by the low productivity and the complexity of the recovered flavonoids. Thus to overcome these limitations, metabolic engineering of specific pathway in microbial systems have been envisaged to produce high quantity of a single molecules. Result: Saccharomyces cerevisiae was engineered to produce the key intermediate flavonoid, naringenin, solely from glucose. For this, specific naringenin biosynthesis genes from Arabidopsis thaliana were selected by comparative expression profiling and introduced in S. cerevisiae. The sole expression of these A. thaliana genes yielded low extracellular naringenin concentrations (<5.5 mu M). To optimize naringenin titers, a yeast chassis strain was developed. Synthesis of aromatic amino acids was deregulated by alleviating feedback inhibition of 3-deoxy-d-arabinose-heptulosonate-7-phosphate synthase (Aro3, Aro4) and byproduct formation was reduced by eliminating phenylpyruvate decarboxylase (Aro10, Pdc5, Pdc6). Together with an increased copy number of the chalcone synthase gene and expression of a heterologous tyrosine ammonia lyase, these modifications resulted in a 40 fold increase of extracellular naringenin titers (to approximately 200 mu M) in glucose-grown shake flask cultures. In aerated, pH controlled batch reactors, extracellular naringenin concentrations of over 400 mu M were reached. Conclusion: The results reported in this study demonstrate that S. cerevisiae is capable of de novo production of naringenin by coexpressing the naringenin production genes from A. thaliana and optimization of the flux towards the naringenin pathway. The engineered yeast naringenin production host provides a metabolic chassis for production of a wide range of flavonoids and exploration of their biological functions.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Engineering Saccharomyces cerevisiae for the de novo Production of Halogenated Tryptophan and Tryptamine Derivatives
    Milne, Nicholas
    Saez-Saez, Javier
    Nielsen, Annette Munch
    Dyekjaer, Jane Dannow
    Rago, Daniela
    Kristensen, Mette
    Wulff, Tune
    Borodina, Irina
    CHEMISTRYOPEN, 2023, 12 (04):
  • [32] De novo Biosynthesis of 3-O-glucosylation Oleanolic Acid in Engineered Saccharomyces cerevisiae
    Zhao, Yujia
    Fan, Peilei
    Liang, Liang
    Liu, Yinyin
    Zhao, Haibo
    Shen, Zhengsheng
    Bai, Jingwei
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 127 : 27 - 27
  • [33] Pathway elucidation of bioactive rhamnosylated ginsenosides in Panax ginseng and their de novo high-level production by engineered Saccharomyces cerevisiae
    Li, Chaojing
    Yan, Xing
    Xu, Zhenzhen
    Wang, Yan
    Shen, Xiao
    Zhang, Lei
    Zhou, Zhihua
    Wang, Pingping
    COMMUNICATIONS BIOLOGY, 2022, 5 (01)
  • [34] Pathway elucidation of bioactive rhamnosylated ginsenosides in Panax ginseng and their de novo high-level production by engineered Saccharomyces cerevisiae
    Chaojing Li
    Xing Yan
    Zhenzhen Xu
    Yan Wang
    Xiao Shen
    Lei Zhang
    Zhihua Zhou
    Pingping Wang
    Communications Biology, 5
  • [35] Saccharomyces cerevisiae biofactory to produce naringenin using a systems biology approach and a bicistronic vector expression strategy in flavonoid production
    Mejia-Manzano, Luis Alberto
    Ortiz-Alcaraz, Cesar Ivan
    Daza, Laura E. Parra
    Medina, Lina Suarez
    Vargas-Cortez, Teresa
    Fernandez-Nino, Miguel
    Barrios, Andres Fernando Gonzalez
    Gonzalez-Valdez, Jose
    MICROBIOLOGY SPECTRUM, 2024, 12 (01):
  • [36] Production of miltiradiene by metabolically engineered Saccharomyces cerevisiae
    Dai, Zhubo
    Liu, Yi
    Huang, Luqi
    Zhang, Xueli
    BIOTECHNOLOGY AND BIOENGINEERING, 2012, 109 (11) : 2845 - 2853
  • [37] Production of (R)-citramalate by engineered Saccharomyces cerevisiae
    Mitsui, Ryosuke
    Kondo, Akihiko
    Shirai, Tomokazu
    METABOLIC ENGINEERING COMMUNICATIONS, 2024, 19
  • [38] Production of (-)-α-bisabolol in metabolically engineered Saccharomyces cerevisiae
    Kim, Tae Yeob
    Park, Haeseong
    Kim, Sun-Ki
    Kim, Soo-Jung
    Park, Yong-Cheol
    JOURNAL OF BIOTECHNOLOGY, 2021, 340 : 13 - 21
  • [39] Engineered mitochondrial production of monoterpenes in Saccharomyces cerevisiae
    Yee, Danielle A.
    DeNicola, Anthony B.
    Billingsley, John M.
    Creso, Jenette G.
    Subrahmanyam, Vidya
    Tang, Yi
    METABOLIC ENGINEERING, 2019, 55 : 76 - 84
  • [40] De novo biosynthesis of carminic acid in Saccharomyces cerevisiae
    Zhang, Qian
    Wang, Xinglong
    Zeng, Weizhu
    Xu, Sha
    Li, Dong
    Yu, Shiqin
    Zhou, Jingwen
    METABOLIC ENGINEERING, 2023, 76 : 50 - 62